NATIONAL HARBOR, Md., June 13, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the presentation of real-world data for the treatment of patients with carotid artery disease at risk for stroke at the Society for Vascular Surgery 2019 Vascular Annual Meeting (VAM). In a headline presentation, Dr. Mahmoud Malas of the University of California, San Diego School of Medicine shared updated results for the ongoing TransCarotid Artery Revascularization (TCAR) Surveillance Project.
The results of the TCAR Surveillance Project are overwhelmingly positive on a large dataset of patients, showing, for the first time, significantly lower odds of composite in-hospital stroke, death and myocardial infarction compared to CEA. TCAR had statistically equivalent in-hospital stroke and death rates as CEA, with significantly lower odds of myocardial infarction and cranial nerve injury. Additionally, there was a significant reduction in mortality at 30 days and 1 year, likely attributable to the reduction in myocardial infarction,” Dr. Malas said. “Patients clearly benefit from TCAR’s less-invasive approach and with these data and future studies with similar results, I believe TCAR may become the standard of care.”
Read More: https://www.globenewswire.com/news-release/2019/06/13/1868408/0/en/TCAR-Achieves-Favorable-Outcomes-vs-Carotid-Endarterectomy-in-Patients-with-Carotid-Artery-Disease.html
TCAR Achieves Favorable Outcomes vs. Carotid Endarterectomy in Patients with Carotid Artery Disease6/13/2019
Via: GlobeNewswire SUNNYVALE, Calif. – June 4, 2019 – Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced key data from the SVS TCAR Surveillance Project and ROADSTER-2 study will be presented at the upcoming Society for Vascular Surgery 2019 Vascular Annual Meeting (VAM), June 12-15 at the Gaylord National Resort & Convention Center in National Harbor, Maryland. Seeking to save billions of dollars, employers turn to Bay Area companies to help with diabetes5/22/2019
For diabetic workers, access to a refrigerator and insulin breaks are not a workplace perk. They are potentially a matter of life and death. Via: The Carle Foundation The signs of Robert Nemeth’s mini-stroke were clear.
“I was standing in front of the refrigerator, and my right arm wouldn’t move. I realized something was very wrong,” Nemeth said. The Sadorus man needed a procedure to help clear his carotid artery, which was 90 percent blocked. Because of previous radiation treatments to his neck, traditional surgery could have been risky. Thankfully, surgeons at Carle Heart & Vascular Institute perform a minimally invasive procedure to reach the carotid artery through a small incision in the clavicle. Carle is the only Illinois hospital outside the Chicago and St. Louis areas to offer TransCarotid Artery Revascularization (TCAR). “This is the future,” said Carle vascular surgeon Brian Beeman, MD. “TCAR is a much safer option for patients who are at high risk for traditional surgery, including patients with congestive heart failure and recent heart attack.” Read More: https://newsroom.carle.org/quality-innovation/stroke-prevention-procedure-serves-as-option-for-high-risk-patients.htm Via: Kinston Gary Sunderland was recovering from a heart procedure at New Hanover Regional Medical Center when a physician assistant stopped by to assess him. Using a stethoscope, the physician assistant listened to the carotid artery in his neck. Via: MassDevice Stealthy catheter developer Route 92 Medical, which is developing a catheter to treat stroke, last week said it raised nearly $13 million in an equity round. Via: GlobeNewsWire SUNNYVALE, Calif., May 08, 2019 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2019. Via: BusinessWire Company’s Research Initiative Recognized as Novel, Innovative Approach to Deliver More Personalized Dialysis Treatment Via: The Times-News The Centers for Disease Control and Prevention reports that nearly 800,000 people in the United States have suffered strokes. Stroke Awareness Month, which occurs in May, is quickly approaching, which makes this a good time to discuss the medical advances in this area. Thankfully, the medical field is rapidly advancing, and new techniques and procedures are created every year. Transcarotid artery revascularization (TCAR) is one such procedure that can change the lives of patients at risk for stroke. Shares of Silk Road Medical (SILK) popped more than 80% on Thursday with an initial public offering that drew heavy interest from investors. The Silk Road Medical IPO raised $120 million. |
Archives
October 2023
|